MEI Pharma Inc (NASDAQ:MEIP) just received Breakthrough Therapy Designation for its key pipeline drug pracinostat, anti-tumor molecule inhibitor that combined with azacitidine treats …
In a research report issued yesterday, Wedbush analyst Heather Behanna reiterated a Buy rating and $6.00 price target on shares of Idera Pharmaceuticals Inc (NASDAQ:IDRA), …
Wedbush analyst, Aaron Turner , reiterates his Neutral rating on RetailMeNot Inc. (NASDAQ:SALE), with a price target of $10.
Analyst Steve Koenig of Wedbush discussed his expectations for FireEye Inc (NASDAQ:FEYE) upcoming second-quarter earnings report that is set to be released after markets …
Analyst Nick McKay from Wedbush previewed Fitbit Inc (NYSE:FIT) ahead of its second-quarter earnings that will be released tomorrow after closing. The analyst is …
Analyst Nick McKay of Wedbush believes that GoPro Inc (NASDAQ:GPRO) may be prime for a turnaround after a rough six months. The last …
Ahead of second quarter earnings to be reported after market close on Thursday, August 4th, Wedbush analyst Michael Pachter remains bullish on video game publishing …
Wedbush analyst Michael Pachter is out with a favorable report on Amazon.com, Inc.
Following disappointing second quarter earnings reported Tuesday, July 26, Twitter Inc (NYSE:TWTR) is under hot water right now with investors, with the stock …
Analyst Gil Luria of Wedbush reiterated his Outperform rating for Paypal Holdings Inc (NASDAQ:PYPL) with a price target of $50, marking a 32% …
